Group by:
Date |
Item TypeArticle
A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response.
Denker, S. and Bittner, A. and Na, I.K. and Kase, J. and Frick, M. and Anagnostopoulos, I. and Hummel, M. and Schmitt, C.A.
International Journal of Hematologic Oncology 8
(4): IJH20.
19 December 2019
This list was generated on Wed May 1 02:28:55 2024 CEST.